Hospital News and Research

RSS

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.

31 Mar 2010

United Anesthesia Services deploys Quantum Clinical Navigation System in Bryn Mawr Hospital

United Anesthesia Services, P.C. has taken the lead in the Pennsylvania marketplace regarding its commitment to patient quality by deploying the Quantum Clinical Navigation System™ in Bryn Mawr Hospital.

31 Mar 2010

Asclera injection receives FDA approval

The U.S. Food and Drug Administration today approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

31 Mar 2010

Facts and treatment options for endometriosis

One out of every two women struggling to conceive may suffer from endometriosis - the leading cause of infertility - according to research from Camran Nezhat, M.D., gynecologist at El Camino Hospital, the hospital of the Silicon Valley.

31 Mar 2010

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.

30 Mar 2010

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

NovaBay Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today reported full-year and fourth quarter financial results for 2009. The company also highlighted recent progress of its proprietary and partnered development programs.

30 Mar 2010

Pennsylvania Patient Safety Authority hires two Patient Safety Liaisons for Southeast region

The Pennsylvania Patient Safety Authority has hired its final two Patient Safety Liaisons for the Southeast region to serve as educational patient safety consultants to healthcare facilities that submit reports through the Pennsylvania Patient Safety Reporting System.

30 Mar 2010

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

Bayshore Home Health, Canada's largest provider of home and community health care services, is installing WinMagic's SecureDoc full-disk encryption software on all laptops and tablets used by the company, including those utilized by clinical managers and nurses.

30 Mar 2010

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals Inc. has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. Acetadote was launched by Cumberland in 2004 as the first U.S.-approved injectable drug to treat acetaminophen overdose.

30 Mar 2010

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Modular Building Institute has named MedBuild, a healthcare division of ModSpace, first-place winner for their 2010 Awards of Distinction. MBI gave MedBuild top honors in its permanent healthcare category for its construction of the patient-ready imaging suite at Nash General Hospital in Rocky Mount, N.C.

30 Mar 2010

Ohio Board of Pharmacy approves CPSI's CPOE, E-MAR and Pharmacy applications

Computer Programs and Systems, Inc., a leading provider of healthcare information technology to community and specialty hospitals, announced today that the Computerized Physician Order Entry (CPOE), Electronic Medication Administration Record (E-MAR) and Pharmacy applications of the CPSI System have achieved "approvable" status from the Ohio Board of Pharmacy. To achieve "approvable" status, CPSI worked with the Board to enhance the security of CPSI's medication management solutions and validate compliance with the Board's standards for the integration of positive caregiver identification.

30 Mar 2010

Study suggests two distinct versions of multiple sclerosis

There may be two distinct versions of multiple sclerosis, a study in both animal models and human blood samples suggests. What's more, a patient's responsiveness to the most popular first-line drug for this episodic and all-too-often recurring autoimmune condition seems to depend on which version that patient has.

30 Mar 2010

Chocolate can lower blood pressure and reduce risk of heart disease: Study

Easter eggs and other chocolate may be good for you - at least in small quantities and preferably if it's dark chocolate - according to research that shows just one small square of chocolate a day can lower your blood pressure and reduce your risk of heart disease. The study is published online today (Wednesday 31 March) in the European Heart Journal.

30 Mar 2010

A-Life Medical renews extensive contract for CAC services with Associated Billing Services

A-Life Medical, Inc., the pioneer and leading provider of computer-assisted coding (CAC) products and services to the healthcare industry, announced today the renewal of an extensive contract with Associated Billing Services, Inc. Associated Billing Services provides medical billing and accounts receivable management services throughout Arizona. The company has worked with A-Life Medical for four years.

30 Mar 2010

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

Leading preventive health care researchers, physicians and executives assembled at U.S. Preventive Medicine® Friday to outline their vision for advancing evidence-based prevention in health care.

30 Mar 2010

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise and highly effective form of radiotherapy to treat cancer.

30 Mar 2010

Research: Having large number of supportive relatives increases fear of dying among elderly

Having a large number of supportive relatives increases the fear of dying among the elderly from ethnic minority groups, suggests research in Postgraduate Medical Journal.

30 Mar 2010

Mutations in gene protecting body leads to development of cancer

An important gene that normally protects the body against cancer can itself cause a variety of cancers depending on the specific mutation that damages it, according to a new study by investigators at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).

30 Mar 2010

Silence Therapeutics, Dainippon Sumitomo Pharma announce expansion of siRNA delivery collaboration

Silence Therapeutics plc today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in August 2009, the companies are leveraging Silence's proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate functional delivery of RNA interference (RNAi) therapeutics to specific disease targets in the body.

30 Mar 2010

New DNA test to detect Lyme disease spirochete infection

Many of the more than 30,000 people a year in the United States with suspected cases of Lyme disease spirochete (bacterial) infection can now take a DNA test developed by a Connecticut scientist/physician and his team that can quickly determine if they test positive for Lyme spirochetes in their blood.

30 Mar 2010

Hospital News and Research

QRxPharma initiates Phase 1 trial for evaluating PK profiles of morphine, oxycodone CR formulations

United Anesthesia Services deploys Quantum Clinical Navigation System in Bryn Mawr Hospital

Asclera injection receives FDA approval

Facts and treatment options for endometriosis

Multi-center clinical trial of MyoSure Hysteroscopic Tissue Removal System initiated

NovaBay Pharmaceuticals reports net income of $2.7M for 2009 against year-ago loss

Pennsylvania Patient Safety Authority hires two Patient Safety Liaisons for Southeast region

Bayshore Home Health deploys WinMagic's SecureDoc full-disk encryption software

Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure

MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project

Ohio Board of Pharmacy approves CPSI's CPOE, E-MAR and Pharmacy applications

Study suggests two distinct versions of multiple sclerosis

Chocolate can lower blood pressure and reduce risk of heart disease: Study

A-Life Medical renews extensive contract for CAC services with Associated Billing Services

Preventive health care researchers meet to outline vision for evidence-based prevention in health care

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Research: Having large number of supportive relatives increases fear of dying among elderly

Mutations in gene protecting body leads to development of cancer

Silence Therapeutics, Dainippon Sumitomo Pharma announce expansion of siRNA delivery collaboration

New DNA test to detect Lyme disease spirochete infection

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News